PTAB Invalidated Stratasys 3D Printer Patent Claims
The board ruled several challenged claims in Stratasys patents for 3D printing technology are obvious.
Updated on Oct. 1, 2026 in Biotech
Live Poll
Do you trust the current patent system to fairly handle challenges to jury-awarded damages?
The Patent Trial and Appeal Board has invalidated nearly all challenged claims across three patents held by Stratasys. The decision affects a portion of a previously awarded trial judgment.
Why it matters
This ruling reduces the legal leverage of Stratasys in its ongoing intellectual property disputes within the 3D printing sector. It highlights the vulnerability of existing patents when subjected to rigorous scrutiny by the patent board.
The Patent Trial and Appeal Board declared claims regarding 3D printer technology invalid on the basis of obviousness. These specific claims supported $2.8 million of a larger $27.6 million judgment initially reached in Texas.
The players
Stratasys
Stratasys is a global leader in additive manufacturing and 3D printing solutions.
Bambu Lab Ltd.
Bambu Lab Ltd. is a consumer-focused 3D printer manufacturer that challenged the Stratasys patents.
Patent Trial and Appeal Board
The Patent Trial and Appeal Board is an administrative body within the U.S. Patent and Trademark Office that reviews patent validity.
The details
The board found that the disputed patent claims submitted by Stratasys were not inventive enough to warrant patent protection. Bambu Lab Ltd. successfully initiated the challenge that led to this invalidation of the Stratasys intellectual property.
Timeline
September 30, 2026: The Patent Trial and Appeal Board invalidated the Stratasys patent claims.
The Tech Race
This development underscores a broader trend of aggressive patent challenges within the additive manufacturing industry. It signals a shift where established players face increased scrutiny from emerging competitors regarding the validity of their legacy intellectual property portfolios.
The invalidation of these patent claims may lower barriers for competitors to introduce similar 3D printing technologies to the market. Consumers could benefit from increased product variety and potentially more competitive pricing in the near future.
The takeaway
Intellectual property remains a highly contested battlefield where even significant trial victories are subject to reversal through administrative review. Companies must ensure their technical claims are robust enough to withstand challenges based on obviousness standards.
Further reading
For more on evolving standards in intellectual property, explore the Biotech section.
Source note: This article includes information reported by Law360.
Live Poll
Do you trust the current patent system to fairly handle challenges to jury-awarded damages?
